FcRg-deficient human NK cells with protein Ab-dependent, anti-viral responsiveness
Dr. Sungjin Kim was awarded a five year grant from the National Institute of Allergy and Infectious Diseases, NIH. Recently, we have identified a novel subset of human natural killer (NK) cells that have potent anti-viral activity. The proposed study will address how these NK cells are generated and maintained, and how they function better than conventional NK cells. This research will not only increase our understanding of the biology of these NK cells, but also provide new approaches for harnessing the power and therapeutic benefits of these NK cells in clinical settings in the context of viral infection and cancer.